FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.

Medicine (Baltimore) · 2018 · PMC6320186 · PMID 30572498

Europe PMC DOI

hedged sentence

0.2140

closest p · 4.3× alpha

0.2140

boldest claim

The sentences

a strong trendP = .214not close (p > 0.1)

The overall results showed that there was a strong trend but no statistical difference between the FIB-4 index and DFS in HCC patients (HR = 1.53, 95% CI: 0.89–2.18) using a fixed-effect model (I 2 = 35.1%, P = .214) (Fig. 4 ). 3.4.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.